Education
About Us
Working with TipRanks
Follow Us
Tharimmune (THAR)
NASDAQ:THAR
Nalmefene
Pruritus, Primary Biliary Cholangitis
Phase II
Not Yet Recruiting
TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis
Dec 03, 2024
―
Nalmefene
Healthy
Phase I
Completed
An Evaluation of The Absolute Bioavailability of TH104
Dec 27, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Tharimmune (THAR) have in its pipeline
THAR is currently developing the following drugs: Nalmefene, Nalmefene. These drug candidates are in various stages of clinical development as the company works toward FDA approval.